Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
delorazepam gaba(a) receptor benzodiazepine binding site small molecule NA drugbank Anxiety Disorders[MeSHID:D001008]
Withdrawal Symptoms[MeSHID:D013375]
Anxiety[MeSHID:D001007]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
NA experimental,illicit ligand
delorazepam gaba(a) receptor small molecule NA drugbank Anxiety Disorders[MeSHID:D001008]
Withdrawal Symptoms[MeSHID:D013375]
Anxiety[MeSHID:D001007]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
NA experimental,illicit positive allosteric modulator
delorazepam gaba(a) receptor small molecule NA drugbank Anxiety Disorders[MeSHID:D001008]
Withdrawal Symptoms[MeSHID:D013375]
Anxiety[MeSHID:D001007]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
NA experimental,illicit positive allosteric modulator
delorazepam gaba(a) receptor benzodiazepine binding site small molecule NA drugbank Anxiety Disorders[MeSHID:D001008]
Withdrawal Symptoms[MeSHID:D013375]
Anxiety[MeSHID:D001007]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
NA experimental,illicit ligand
delorazepam gaba(a) receptor small molecule NA drugbank Anxiety Disorders[MeSHID:D001008]
Withdrawal Symptoms[MeSHID:D013375]
Anxiety[MeSHID:D001007]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
NA experimental,illicit positive allosteric modulator
delorazepam gaba(a) receptor benzodiazepine binding site small molecule NA drugbank Anxiety Disorders[MeSHID:D001008]
Withdrawal Symptoms[MeSHID:D013375]
Anxiety[MeSHID:D001007]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
NA experimental,illicit ligand
delorazepam gaba(a) receptor small molecule NA drugbank Anxiety Disorders[MeSHID:D001008]
Withdrawal Symptoms[MeSHID:D013375]
Anxiety[MeSHID:D001007]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
NA experimental,illicit positive allosteric modulator
delorazepam gaba(a) receptor benzodiazepine binding site small molecule NA drugbank Anxiety Disorders[MeSHID:D001008]
Withdrawal Symptoms[MeSHID:D013375]
Anxiety[MeSHID:D001007]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
NA experimental,illicit ligand
delorazepam gaba(a) receptor small molecule NA drugbank Anxiety Disorders[MeSHID:D001008]
Withdrawal Symptoms[MeSHID:D013375]
Anxiety[MeSHID:D001007]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
NA experimental,illicit positive allosteric modulator
delorazepam gaba(a) receptor small molecule NA drugbank Anxiety Disorders[MeSHID:D001008]
Withdrawal Symptoms[MeSHID:D013375]
Anxiety[MeSHID:D001007]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
NA experimental,illicit positive allosteric modulator
delorazepam gaba(a) receptor small molecule NA drugbank Anxiety Disorders[MeSHID:D001008]
Withdrawal Symptoms[MeSHID:D013375]
Anxiety[MeSHID:D001007]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
NA experimental,illicit positive allosteric modulator
delorazepam gaba(a) receptor small molecule NA drugbank Anxiety Disorders[MeSHID:D001008]
Withdrawal Symptoms[MeSHID:D013375]
Anxiety[MeSHID:D001007]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
NA experimental,illicit positive allosteric modulator
delorazepam gaba(a) receptor small molecule NA drugbank Anxiety Disorders[MeSHID:D001008]
Withdrawal Symptoms[MeSHID:D013375]
Anxiety[MeSHID:D001007]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
NA experimental,illicit positive allosteric modulator
delorazepam gaba(a) receptor small molecule NA drugbank Anxiety Disorders[MeSHID:D001008]
Withdrawal Symptoms[MeSHID:D013375]
Anxiety[MeSHID:D001007]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
NA experimental,illicit positive allosteric modulator
delorazepam gaba(a) receptor small molecule NA drugbank Anxiety Disorders[MeSHID:D001008]
Withdrawal Symptoms[MeSHID:D013375]
Anxiety[MeSHID:D001007]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
NA experimental,illicit positive allosteric modulator
delorazepam gaba(a) receptor benzodiazepine binding site small molecule NA drugbank Anxiety Disorders[MeSHID:D001008]
Withdrawal Symptoms[MeSHID:D013375]
Anxiety[MeSHID:D001007]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
NA experimental,illicit ligand
delorazepam gaba(a) receptor small molecule NA drugbank Anxiety Disorders[MeSHID:D001008]
Withdrawal Symptoms[MeSHID:D013375]
Anxiety[MeSHID:D001007]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
NA experimental,illicit positive allosteric modulator
delorazepam gaba(a) receptor benzodiazepine binding site small molecule NA drugbank Anxiety Disorders[MeSHID:D001008]
Withdrawal Symptoms[MeSHID:D013375]
Anxiety[MeSHID:D001007]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
NA experimental,illicit ligand
delorazepam gaba(a) receptor small molecule NA drugbank Anxiety Disorders[MeSHID:D001008]
Withdrawal Symptoms[MeSHID:D013375]
Anxiety[MeSHID:D001007]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
NA experimental,illicit positive allosteric modulator
delorazepam gaba(a) receptor benzodiazepine binding site small molecule NA drugbank Anxiety Disorders[MeSHID:D001008]
Withdrawal Symptoms[MeSHID:D013375]
Anxiety[MeSHID:D001007]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
NA experimental,illicit ligand
delorazepam gaba(a) receptor small molecule NA drugbank Anxiety Disorders[MeSHID:D001008]
Withdrawal Symptoms[MeSHID:D013375]
Anxiety[MeSHID:D001007]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
NA experimental,illicit positive allosteric modulator
delorazepam gaba(a) receptor small molecule NA drugbank Anxiety Disorders[MeSHID:D001008]
Withdrawal Symptoms[MeSHID:D013375]
Anxiety[MeSHID:D001007]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
NA experimental,illicit positive allosteric modulator
delorazepam gaba(a) receptor small molecule NA drugbank Anxiety Disorders[MeSHID:D001008]
Withdrawal Symptoms[MeSHID:D013375]
Anxiety[MeSHID:D001007]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
NA experimental,illicit positive allosteric modulator
click here to return to the previous page